MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.hpb.2024.07.407

Медицинская библиотека · HPB : the official journal of the International Hepato Pancreato Biliary Association · 2024

Combined portal and hepatic vein embolisation in perihilar cholangiocarcinoma.

Smits Jens, Chau Steven, James Sinéad, Korenblik Remon, Tschögl Madita, Arntz Pieter, Bednarsch Jan, Abreu de Carvalho Luis, Detry Olivier, Erdmann Joris, Gruenberger Thomas, Hermie Laurens, Neumann Ulf, Sandström Per, Sutcliffe Robert, Denys Alban, Melloul Emmanuel, Dewulf Maxime, van der Leij Christiaan, van Dam Ronald M, EuroLVD and DRAGON Trials Collaborative

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Major hepatectomy in perihilar cholangiocarcinoma (pCCA) patients with a small future liver remnant (FLR) risks posthepatectomy liver failure (PHLF). This study examines combined portal and hepatic vein embolisation (PVE/HVE) to increase preoperative FLR volume and potentially decrease PHLF rates.

METHODS

In this retrospective, multicentre, observational study, data was collected from centres affiliated with the DRAGON Trials Collaborative and the EuroLVD registry. The study included pCCA patients who underwent PVE/HVE between July 2016 and January 2023.

RESULTS

Following PVE/HVE, 28% of patients (9/32) experienced complications, with 22% (7/32) necessitating biliary interventions for cholangitis. The median degree of hypertrophy after a median of 16 days was 16% with a kinetic growth rate of 6.8% per week. 69% of patients (22/32) ultimately underwent surgical resection. Cholangitis after PVE/HVE was associated with unresectability. After resection, 55% of patients (12/22) experienced complications, of which 23% (5/22) were Clavien-Dindo grade III or higher. The 90-day mortality after resection was 0%.

CONCLUSION

PVE/HVE quickly enhances the kinetic growth rate in pCCA patients. Cholangitis impairs chances on resection significantly. Resection after PVE/HVE is associated with low levels of 90-day mortality. The study highlights the potential of PVE/HVE in improving safety and outcomes in pCCA undergoing resection.

Для цитирования: Smits Jens, Chau Steven, James Sinéad, Korenblik Remon, Tschögl Madita, Arntz Pieter, Bednarsch Jan, Abreu de Carvalho Luis, Detry Olivier, Erdmann Joris, Gruenberger Thomas, Hermie Laurens, Neumann Ulf, Sandström Per, Sutcliffe Robert, Denys Alban, Melloul Emmanuel, Dewulf Maxime, van der Leij Christiaan, van Dam Ronald M, EuroLVD and DRAGON Trials Collaborative. Combined portal and hepatic vein embolisation in perihilar cholangiocarcinoma.. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2024. DOI: 10.1016/j.hpb.2024.07.407.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.